These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 3235850
1. Changes in receptor status after treatment with tamoxifen in endometrial cancer. Oriana S, Raspagliesi F, Duca PG, Coradini D, Di Re EM, Ragazzi D, Grillo T, Luciani L. Int J Biol Markers; 1988; 3(4):233-6. PubMed ID: 3235850 [Abstract] [Full Text] [Related]
5. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M. Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [Abstract] [Full Text] [Related]
6. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Encarnación CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SA, Osborne CK. Breast Cancer Res Treat; 1993 Mar; 26(3):237-46. PubMed ID: 8251648 [Abstract] [Full Text] [Related]
10. [Comparative study of hormone receptor content and morphologic parameters in endometrial cancer and in non-malignant uterine tissue]. Lück HJ, Hilfrich J, Degenhardt F, Stauch G. Arch Gynecol Obstet; 1989 Mar; 245(1-4):578-80. PubMed ID: 2802743 [No Abstract] [Full Text] [Related]
11. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method]. Kurebayashi J, Horiuchi R, Nakamura T, Iino Y, Ishida T, Takigawa H, Izuo M. Nihon Naibunpi Gakkai Zasshi; 1987 Nov 20; 63(11):1351-63. PubMed ID: 2965035 [Abstract] [Full Text] [Related]
13. Hormonal and receptor status in postmenopausal women with endometrial carcinoma before and after treatment with tamoxifen. Luciani L, Oriana S, Spatti G, Secreto G, Recchione C, Grignoglio E, Andreola S, Coradini D, Ronchi E, Di Fronzo G. Tumori; 1984 Apr 30; 70(2):189-92. PubMed ID: 6428017 [Abstract] [Full Text] [Related]
15. [Hormone dependence of malignant ovarian tumors--an in vitro model]. Schieder K, Bieglmayer C, Kölbl H. Geburtshilfe Frauenheilkd; 1989 May 30; 49(5):437-41. PubMed ID: 2544477 [Abstract] [Full Text] [Related]
16. [Histopathological changes in endometrial cancer treated with tamoxifen]. Lin HH, Ueda K, Kato J. Gan To Kagaku Ryoho; 1986 Apr 30; 13(4 Pt 1):1038-43. PubMed ID: 3963849 [Abstract] [Full Text] [Related]
17. Effects on mouse uterus of three antitumoral drugs acting upon estrogen and progesterone receptors directly and through other transduction pathways. Actis AM, Dorfman VB, Caruso SP, Levin E. Biochem Pharmacol; 1998 Feb 01; 55(3):273-8. PubMed ID: 9484792 [Abstract] [Full Text] [Related]
18. Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma. Bonte J, Ide P, Billiet G, Wynants P. Gynecol Oncol; 1981 Apr 01; 11(2):140-61. PubMed ID: 6783481 [No Abstract] [Full Text] [Related]
19. Effect of tamoxifen on steroid hormone receptors and creatine kinase activity in human endometrial carcinoma. Iacobelli S, Scambia G, Atlante G, Landoni F, Sismondi P, Vecchio FM. Eur J Cancer Clin Oncol; 1986 Jan 01; 22(1):105-10. PubMed ID: 3956553 [Abstract] [Full Text] [Related]
20. Effect of the nonsteroidal antiestrogen ZK 119.010 on growth and metastasis of the EnDA endometrial carcinoma. Horn DW, Vollmer G, von Angerer E, Schneider MR. Int J Cancer; 1994 Aug 01; 58(3):426-9. PubMed ID: 8050824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]